This Pen Needles Market analysis report evaluates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porter’s Five Forces Analysis. Integrated approaches and the latest technology have been exploited for the best results while generating this report. Key elements covered in this business report are industry outlook along with critical success factors, industry dynamics, market definition, drivers and restraints, market segmentation, value chain analysis, key developments, application and technology outlook, regional or country-level analysis, and competitive landscape.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=31...

Key players in the Pen Needles Market

Becton, Dickinson and Company (US),

Novo Nordisk A/S (Denmark),

Ypsomed Holding AG (Switzerland),

B. Braun Melsungen AG (Germany),

Owen Mumford (UK),

Terumo Corporation (Japan),

Nipro Corporation (Japan),

Allison Medical (US),

AdvaCare Pharma (US),

Berpu Medical Technology (China),

ARKRAY (Japan),

GlucoRx (UK),

HTL-STREFA (Poland),

UltiMed, (US),

Hindustan Syringes and Medical Devices (India),

Artsana Group (Italy),

PromiseMed Diabetes Care (Canada),

Montmed (Canada),

Trividia Health (US),

VOGT Medical Vertrieb (Germany),

Van Heek Medical (Netherlands),

Simple Diagnostics (US),

Iyon (Turkey),

Links Medical Products (US),

and MHC Medical Products (US).

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) – Global Forecast to 2026 The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market. The challenges faced by the market are reuse of pen needles and misuse of injection pens.

Research Coverage:

The report analyzes the pen needles market and aims at estimating the market size and future growth potential of this market based on various segments such as type, length, therapy, mode of purchase, and region. The report also includes a product portfolio matrix of various pen needles available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

Market Penetration: Comprehensive information on product portfolios offered by the top players in the global pen needles market. The report analyzes this market by type, therapy, length, and mode of purchase
Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global pen needles market
Market Development: Comprehensive information on the lucrative emerging markets by type, therapy, length, and mode of purchase
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pen needles market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global pen needles market.
Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name...

Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market. The challenges faced by the market are reuse of pen needles and misuse of injection pens.

Based on product type, the standard pen needles segment holds the largest market share during the forecast period.

Based on type, the pen needles market is segmented into standard and safety pen needles. In 2020, the standard pen needles segment accounted for the largest share in the pen needles market. Standard pen needles are preferred over safety pen needles as they are more affordable, especially considering the need for daily insulin intake. The low cost of standard pen needles has also led to their wide adoption in emerging economies such as China, India, and Brazil, where the use of safety pen needles is low to negligible.

Based on length, the 8mm segment grows at the highest market share during the forecast period.

Based on length, the market is segmented into 4mm (5/32’’), 5mm (3/16’’), 6mm (1/4’’), 8mm (5/16’’), 10mm, and 12mm (1/2’’). In 2020, the 8mm segment accounted for the largest share in the pen needles market. The large share of this segment is mainly attributed to the wide adoption of these needles among diabetes patients.

Based on mode of purchase, the retail segment is expected to register the highest CAGR during the forecast period.

Based on the mode of purchase, the market is categorized into retail and non-retail. The retail segment accounted for the largest share and highest growth during the forecast period. The significant discounts offered on online/retail purchases of pen needles, high convenience, increasing awareness on pen needles, and the favorable reimbursement scenario in North America and Europe are some of the key factors driving the growth of the retail segment.

Based on therapy, the insulin therapy segment is expected to register the highest CAGR during the forecast period.

Based on therapy, the market is categorized into insulin therapy, glucagon-like peptide-1 (GLP-1) therapy, growth hormone therapy, and other therapies (osteoporosis, thyroid, obesity). In 2020, insulin therapy held maximum of the global pen needles market, primarily due to the high and growing diabetic population globally. This segment is also expected to grow at the highest rate during the forecast period.

North America is expected to account for the largest share of the pen needles market in 2020

Geographically, the pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the pen needles market in 2020. The growing diabetes prevalence and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies are driving market growth in the US.

Break of primary participants was as mentioned below:

By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
By Designation – C-level–30%, Director-level–50%, Others–20%
By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%
Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions Of The Study
1.2.2 Market Segmentation
1.2.3 Years Considered For The Study
1.3 Currency
1.3.1 Exchange Rates Utilized For The Conversion To Usd
1.4 Limitations
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 4 Breakdown Of Primary Interviews: Supply-Side And Demand-Side Participants (Pen Needles Market)
2.2 Market Size Estimation
Figure 5 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 6 Revenue Share Analysis Illustration: Becton, Dickinson And Company (2020)
Figure 7 Revenue Analysis Of The Top Five Companies: Pen Needles Market (2020)
Figure 8 Demand-Side Analysis
Figure 9 Cagr Projections: Supply-Side Analysis
Figure 10 Cagr Projections From The Analysis Of Drivers, Restraints, Opportunities, And Challenges Of The Pen Needles Market (2021–2026)
Figure 11 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
Figure 12 Market Data Triangulation Methodology
2.4 Market Share Analysis
2.5 Assumptions For The Study
2.6 Risk Assessment
Table 1 Risk Assessment: Pen Needles Market

3 Executive Summary
Figure 13 Pen Needles Market, By Type, 2021 Vs. 2026 (Usd Million)
Figure 14 Pen Needles Market, By Length, 2021 Vs. 2026 (Usd Million)
Figure 15 Pen Needles Market, By Therapy, 2021 Vs. 2026 (Usd Million)
Figure 16 Pen Needles Market, By Mode Of Purchase, 2021 Vs. 2026 (Usd Million)
Figure 17 Geographic Snapshot: Pen Needles Market

4 Premium Insights
4.1 Pen Needles Market Overview
Figure 18 Growing Prevalence Of Chronic Diseases To Drive The Growth Of The Pen Needles Market
4.2 Asia Pacific: Pen Needles Market, By Therapy And Country
Figure 19 Japan Dominates The Apac Market
4.3 Pen Needles Market: Geographic Mix
Figure 20 India & China To Witness The Highest Growth In The Pen Needles Market During The Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Pen Needles Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Growing Prevalence Of Chronic Diseases
Figure 22 Number Of People With Chronic Conditions In The Us, 1995–2030 (Million Individuals)
Figure 23 Estimated Diabetic Population, By Region, 2019 Vs. 2030 Vs. 2040
5.2.1.2 Favorable Reimbursement In Select Countries
5.2.2 Restraints
5.2.2.1 Preference For Alternative Modes Of Drug Delivery
5.2.2.2 Poor Reimbursement Scenario In Developing Countries
5.2.2.3 Needle Anxiety
5.2.3 Opportunities
5.2.3.1 Growing Preference For Biosimilar Drugs
5.2.3.2 Emerging Markets
Table 2 Rising Income Levels In Emerging Countries
5.2.4 Challenges
5.2.4.1 Reuse Of Pen Needles
5.2.4.2 Misuse Of Injection Pens
5.3 Pricing Analysis
Table 3 Pricing Of Pen Needles Available In The Market
5.4 Value Chain Analysis
Figure 24 Pen Needles Market: Value Chain Analysis
5.5 Ecosystem Market Map
Figure 25 Pen Needles Market: Ecosystem Market Map
5.6 Porter’s Five Forces Analysis
Table 4 Pen Needles Market: Porter’s Five Forces Analysis
5.6.1 Intensity Of Competitive Rivalry
5.6.2 Bargaining Power Of Suppliers
5.6.3 Bargaining Power Of Buyers
5.6.4 Threat Of Substitutes
5.6.5 Threat Of New Entrants
5.7 Supply Chain Analysis
Figure 26 Pen Needles Market: Supply Chain Analysis
5.8 Regulatory Analysis
5.8.1 North America
5.8.1.1 Us
Table 5 Us Fda: Medical Device Classification
Table 6 Us: Medical Device Regulatory Approval Process
5.8.1.2 Canada
Table 7 Canada: Medical Device Regulatory Approval Process
Figure 27 Canada: Class Ii Medical Device Approval Process
5.8.2 Europe
Figure 28 Europe: Ce Approval Process For Class Iia Medical Devices
5.8.3 Asia Pacific
5.8.3.1 Japan
Table 8 Japan: Medical Device Classification Under Pmda
5.8.3.2 China
Table 9 China: Regulatory Bodies Appointed For Medical Device Approval
Table 10 China: Classification Of Medical Devices
5.8.3.3 India
5.9 Impact Of Covid-19 On The Pen Needles Market
5.10 Patent Analysis
5.10.1 Patent Publication Trends For Pen Needles
Figure 29 Patent Publication Trends (2011–May 2021)
5.10.2 Insights: Jurisdiction And Top Applicant Analysis
Figure 30 Top Applicants & Owners (Companies/Institutions) For Pen Needles Patents (January 2011–June 2021)
Figure 31 Top Applicant Countries/Regions For Pen Needle Patents (January 2011–June 2021)
5.11 Technology Analysis
5.11.1 Key Technology
5.11.1.1 Fluid Flow Enhancement Technology
5.11.2 Complementary Technology
5.11.2.1 Microfabricated Needles
5.11.3 Adjacent Technology
5.11.3.1 Autoinjectors

6 Pen Needles Market, By Type

Read More……….

Get Discount on the Latest Report @ https://www.reportsnreports.com/contacts/discount.aspx?name=313502